Analysed LIR LIFE SCIENCES CORP (BBCMF:OTCMKTS) News Sources
LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
05-02-2026
yahoo.com
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
29-01-2026
yahoo.com
LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules
22-01-2026
yahoo.com
LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies
15-01-2026
yahoo.com
LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform
08-01-2026
yahoo.com
LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor
18-12-2025
yahoo.com
LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies
11-12-2025
yahoo.com
What is the current price of LIR LIFE SCIENCES CORP (BBCMF:OTCMKTS)?
The current price of LIR LIFE SCIENCES CORP (BBCMF:OTCMKTS) is $0.25.
LIR LIFE SCIENCES CORP (BBCMF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of LIR LIFE SCIENCES CORP (BBCMF:OTCMKTS) since the previous trading day is $0.2.
LIR LIFE SCIENCES CORP (BBCMF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of LIR LIFE SCIENCES CORP (BBCMF:OTCMKTS) since the previous trading day is 400%.
What is the most recent average sentiment score for LIR LIFE SCIENCES CORP (BBCMF:OTCMKTS)?
The most recent average sentiment score for LIR LIFE SCIENCES CORP (BBCMF:OTCMKTS) is 67 out of 100.
What is the most recent average sentiment for LIR LIFE SCIENCES CORP (BBCMF:OTCMKTS)?
The most recent sentiment for LIR LIFE SCIENCES CORP (BBCMF:OTCMKTS) is .
SEC-8K** Filing Available For LIR LIFE SCIENCES CORP (BBCMF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.